-
Notifications
You must be signed in to change notification settings - Fork 21
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
how to compare 2 conditions #123
Comments
You can do the enrichment calculation on all the cells with Nick |
I see thank you. I want to also ask about the Differential Enrichment step. For this step if I have two conditions is it possible to use findmarkers and not findallmarkers between each pair of diseased celltype and healthy celltype? The step I am asking about is below: scRep_example <- performNormalization(scRep_example, all.markers <- FindAllMarkers(scRep_example, |
Yes absolutely you can use Nick |
@ncborcherding I see thank you. Does that mean that MAST in Seurat findmarkers will not be suitable? I want to also ask about the heatmap enrichment plot. Excuse me for my beginner question but for the Hallmark apical surface pathway it seems that it had a very low enrichment score in cluster 11 then after scaling, it has a bright yellow color indicating high enrichment scores compared to all other clusters? Does this mean opposite result after scaling? Same goes for Hallmark allograft rejection it had a high score and not anymore after scaling. Which method to use when having 2 conditions to compare between the celltypes visually? |
I think MAST should be fine - their group actually looks at differential enrichment in their paper.
The normalization is using the number of features expressed per cell as a denominator for the enrichment score. A high enrichment score may be a product of a higher average rank of the gene from the gene set in the cell or a higher number of genes within the gene set expressed by the cell (or a combination of both). After scaling, lower enrichment is seen in cells with a high number of features expressed.
This is a really open ended question - happy to go into more detial if you give me more of a description of what you want. Thanks, |
To do gene set enrichment, do I need to do run the code separately for the diseased and the healthy cells?
The text was updated successfully, but these errors were encountered: